Pfizer also said that the companies will use specially designed temperature controlled thermal conveyors as part of the cold chain infrastructure to distribute the vaccine around the world.

“They can be used as temporary storage units for 15 days by filling with dry ice. Each sender contains a thermal sensor with GPS to track the location and temperature of each vaccine shipment through its pre-established routes taking advantage of Pfizer's extensive distribution network.

Pfizer also said that the companies will use specially designed temperature controlled thermal conveyors as part of the cold chain infrastructure to distribute the vaccine around the world.

“They can be used as temporary storage units for 15 days by filling with dry ice. Each sender contains a thermal sensor with GPS to track the location and temperature of each vaccine shipment through its pre-established routes taking advantage of Pfizer's extensive distribution network.

30 pc will be vaccinated

https://www.sinchew.com.my/content/content_2383992.html

30 pc will be vaccinated

https://www.sinchew.com.my/content/content_2383992.html

https://www.sinchew.com.my/content/content_2383992.html

https://www.sinchew.com.my/content/content_2383992.html

PM: Covid-19 vaccines for 6.4 million Malaysians as early as January next year

https://www.thestar.com.my/news/nation/2020/11/27/pm-covid-19-vaccines-for-64mil-malaysians-next-year

Covid-19 vaccine will be safe for Malaysians, promise Pfizer and BioNtech

https://www.thestar.com.my/news/2020/11/27/covid-19-vaccine-will-be-safe-for-malaysians-promise-pfizer-and-biontech

PM: Covid-19 vaccines for 6.4 million Malaysians as early as January next year

https://www.thestar.com.my/news/nation/2020/11/27/pm-covid-19-vaccines-for-64mil-malaysians-next-year

Covid-19 vaccine will be safe for Malaysians, promise Pfizer and BioNtech

https://www.thestar.com.my/news/2020/11/27/covid-19-vaccine-will-be-safe-for-malaysians-promise-pfizer-and-biontech

...............

the same above will happen in cambodia

PM: Covid-19 vaccines for 6.4 million Malaysians as early as January next year

https://www.thestar.com.my/news/nation/2020/11/27/pm-covid-19-vaccines-for-64mil-malaysians-next-year

Covid-19 vaccine will be safe for Malaysians, promise Pfizer and BioNtech

https://www.thestar.com.my/news/2020/11/27/covid-19-vaccine-will-be-safe-for-malaysians-promise-pfizer-and-biontech

Covid-19 vaccine will be safe for Malaysians, promise Pfizer and BioNtech

https://www.thestar.com.my/news/2020/11/27/covid-19-vaccine-will-be-safe-for-malaysians-promise-pfizer-and-biontech

PM: Covid-19 vaccines for 6.4 million Malaysians as early as January next year


https://www.thestar.com.my/news/nation/2020/11/27/pm-covid-19-vaccines-for-64mil-malaysians-next-year

Covid-19 vaccine will be safe for Malaysians, promise Pfizer and BioNtech

https://www.thestar.com.my/news/2020/11/27/covid-19-vaccine-will-be-safe-for-malaysians-promise-pfizer-and-biontech

Covid-19 vaccine will be safe for Malaysians, promise Pfizer and BioNtech

https://www.thestar.com.my/news/2020/11/27/covid-19-vaccine-will-be-safe-for-malaysians-promise-pfizer-and-biontech

Covid-19 vaccine will be safe for Malaysians, promise Pfizer and BioNtech

https://www.thestar.com.my/news/2020/11/27/covid-19-vaccine-will-be-safe-for-malaysians-promise-pfizer-and-biontech

PM: Covid-19 vaccines for 6.4 million Malaysians as early as January next year

https://www.thestar.com.my/news/nation/2020/11/27/pm-covid-19-vaccines-for-64mil-malaysians-next-year

PM: Covid-19 vaccines for 6.4 million Malaysians as early as January next year

https://www.thestar.com.my/news/nation/2020/11/27/pm-covid-19-vaccines-for-64mil-malaysians-next-year

PM: Covid-19 vaccines for 6.4 million Malaysians as early as January next year

https://www.thestar.com.my/news/nation/2020/11/27/pm-covid-19-vaccines-for-64mil-malaysians-next-year

rock solid... this is serious business

by opening comment box....uncle now wants to read the retailers mind....

retailers,

please tell what you all think on supermax...and what shares will be the next theme play...like O&G or tourism (genm , airasia) or..plantation...tell tell please

uncle now wants to read the retailers mind....

retailers,

please tell what you all think on supermax...and what shares will be the next theme play...like O&G or tourism (genm , airasia) or..plantation...tell tell please

Walao...uncle open comment box kah? Omg...

please comment properly with courtesy ah...

this is a RM3 stock just before covid.....

only thing changed is the covid restrictions...even the oil price does not affect its activity much

4 months is what it takes for mass vaccination completion

minimum 2.50 within 4 months...you cannot go wrong.

uncle just need to sneeze about dayang...the whole O&G stocks will be awaken...LOL!

Posted by pang72 > Nov 25, 2020 10:25 AM | Report Abuse

After uncle yy losing more money in glove stock, he will buy back Dayang at rm2

This company had proven under the toughest test, it still generates fantastic cash... the vessel Topaz only sank, its not lost.

There will be pent up maintenance activities even under monsoon season.

No longer makes sense to wait until another qtr to buy....by then it would be too late

Fantastic results... a gem yet to be discovered. Wonder can limit up?

The first Americans to receive a Covid-19 vaccine could get it as soon as 11 December, according to the head of the US coronavirus vaccine programme.

Dr Moncef Slaoui told US network CNN the plan was to "ship vaccines to the immunisation sites within 24 hours" of a vaccine being approved.

https://www.bbc.com/news/world-us-canada-55036381

https://www.bbc.com/news/world-us-canada-55036381

The first Americans to receive a Covid-19 vaccine could get it as soon as 11 December, according to the head of the US coronavirus vaccine programme.

Dr Moncef Slaoui told US network CNN the plan was to "ship vaccines to the immunisation sites within 24 hours" of a vaccine being approved.

https://www.bbc.com/news/world-us-canada-55036381

The first Americans to receive a Covid-19 vaccine could get it as soon as 11 December, according to the head of the US coronavirus vaccine programme.

Dr Moncef Slaoui told US network CNN the plan was to "ship vaccines to the immunisation sites within 24 hours" of a vaccine being approved.

The first Americans to receive a Covid-19 vaccine could get it as soon as 11 December, according to the head of the US coronavirus vaccine programme.

Dr Moncef Slaoui told US network CNN the plan was to "ship vaccines to the immunisation sites within 24 hours" of a vaccine being approved.


https://www.bbc.com/news/world-us-canada-55036381

The first Americans to receive a Covid-19 vaccine could get it as soon as 11 December, according to the head of the US coronavirus vaccine programme.

Dr Moncef Slaoui told US network CNN the plan was to "ship vaccines to the immunisation sites within 24 hours" of a vaccine being approved.


https://www.bbc.com/news/world-us-canada-55036381

Under NHS England’s draft covid-19 vaccine deployment programme, which was outlined in a leaked document dated 13 November seen by HSJ, most doses of the potential vaccine would be administered between early January and mid-March, at a rate of between 4 and 5 million each week.

The vaccinations would take place at thousands of “community mass vaccination sites” arranged by local GPs, with additional “large scale mass vaccination centres” in stadiums and conference centres. Priority will be given to healthcare workers and care home residents who would start to be vaccinated in early December, followed by people aged 80 and above, those in their seventies and those in their late sixties.

Read more: https://www.newscientist.com/article/2237475-covid-19-news-nhs-drafts-plan-to-vaccinate-adults-in-england-by-april/#ixzz6eRCQ0knK

.......

4-5 million per week? by April covid war is completely over looks like

as it happens in US & UK...it will take place worldwide

Under NHS England’s draft covid-19 vaccine deployment programme, which was outlined in a leaked document dated 13 November seen by HSJ, most doses of the potential vaccine would be administered between early January and mid-March, at a rate of between 4 and 5 million each week.

The vaccinations would take place at thousands of “community mass vaccination sites” arranged by local GPs, with additional “large scale mass vaccination centres” in stadiums and conference centres. Priority will be given to healthcare workers and care home residents who would start to be vaccinated in early December, followed by people aged 80 and above, those in their seventies and those in their late sixties.

Read more: https://www.newscientist.com/article/2237475-covid-19-news-nhs-drafts-plan-to-vaccinate-adults-in-england-by-april/#ixzz6eRCQ0knK


.......


4-5 million per week? by April covid war is 100% over looks like

Under NHS England’s draft covid-19 vaccine deployment programme, which was outlined in a leaked document dated 13 November seen by HSJ, most doses of the potential vaccine would be administered between early January and mid-March, at a rate of between 4 and 5 million each week.

The vaccinations would take place at thousands of “community mass vaccination sites” arranged by local GPs, with additional “large scale mass vaccination centres” in stadiums and conference centres. Priority will be given to healthcare workers and care home residents who would start to be vaccinated in early December, followed by people aged 80 and above, those in their seventies and those in their late sixties.

Read more: https://www.newscientist.com/article/2237475-covid-19-news-nhs-drafts-plan-to-vaccinate-adults-in-england-by-april/#ixzz6eRCQ0knK


.......


4-5 million per week? by April covid war is 100% over looks like

Under NHS England’s draft covid-19 vaccine deployment programme, which was outlined in a leaked document dated 13 November seen by HSJ,
...........................................................

https://www.newscientist.com/article/2237475-covid-19-news-nhs-drafts-plan-to-vaccinate-adults-in-england-by-april/


Most doses of the potential vaccine would be administered between early January and mid-March, at a rate of between 4 and 5 million each week.

The vaccinations would take place at thousands of “community mass vaccination sites” arranged by local GPs, with additional “large scale mass vaccination centres” in stadiums and conference centres.

Priority will be given to healthcare workers and care home residents who would start to be vaccinated in early December, followed by people aged 80 and above, those in their seventies and those in their late sixties.


......


4-5 million a week? by April looks like covid war is 100% over.

Under NHS England’s draft covid-19 vaccine deployment programme, which was outlined in a leaked document dated 13 November seen by HSJ,
...........................................................

https://www.newscientist.com/article/2237475-covid-19-news-nhs-drafts-plan-to-vaccinate-adults-in-england-by-april/


Most doses of the potential vaccine would be administered between early January and mid-March, at a rate of between 4 and 5 million each week.

The vaccinations would take place at thousands of “community mass vaccination sites” arranged by local GPs, with additional “large scale mass vaccination centres” in stadiums and conference centres.

Priority will be given to healthcare workers and care home residents who would start to be vaccinated in early December, followed by people aged 80 and above, those in their seventies and those in their late sixties.


......


4-5 million a week? by April looks like covid war is 100% over.

Five federal agencies have started telling employees they could receive Pfizer or Moderna’s Covid-19 vaccine in as little as eight weeks as the U.S. prepares to distribute the potentially life-saving doses across the country, according to a person with first-hand knowledge of the plan.

https://www.cnbc.com/2020/11/20/coronavirus-5-us-agencies-have-started-telling-employees-they-could-get-vaccine-shots-in-8-weeks.html

Five federal agencies have started telling employees they could receive Pfizer or Moderna’s Covid-19 vaccine in as little as eight weeks as the U.S. prepares to distribute the potentially life-saving doses across the country, according to a person with first-hand knowledge of the plan.

https://www.cnbc.com/2020/11/20/coronavirus-5-us-agencies-have-started-telling-employees-they-could-get-vaccine-shots-in-8-weeks.html

Five U.S. agencies have started telling employees they could get Covid vaccine shots in as little as 8 weeks

https://www.cnbc.com/2020/11/20/coronavirus-5-us-agencies-have-started-telling-employees-they-could-get-vaccine-shots-in-8-weeks.html

Five federal agencies have started telling employees they could receive Pfizer or Moderna’s Covid-19 vaccine in as little as eight weeks as the U.S. prepares to distribute the potentially life-saving doses across the country, according to a person with first-hand knowledge of the plan.

Essential federal workers would be among the first group of Americans to get inoculated against the coronavirus after the nation’s health-care workers, according to the Centers for Disease Control’s vaccination program “interim playbook.” The plan lists essential workers, along with the elderly and other highly vulnerable groups, in the first phase of its vaccine distribution plan,

Five U.S. agencies have started telling employees they could get Covid vaccine shots in as little as 8 weeks

https://www.cnbc.com/2020/11/20/coronavirus-5-us-agencies-have-started-telling-employees-they-could-get-vaccine-shots-in-8-weeks.html

Five federal agencies have started telling employees they could receive Pfizer or Moderna’s Covid-19 vaccine in as little as eight weeks as the U.S. prepares to distribute the potentially life-saving doses across the country, according to a person with first-hand knowledge of the plan.

Essential federal workers would be among the first group of Americans to get inoculated against the coronavirus after the nation’s health-care workers, according to the Centers for Disease Control’s vaccination program “interim playbook.” The plan lists essential workers, along with the elderly and other highly vulnerable groups, in the first phase of its vaccine distribution plan,

no , it may 3 weeks

https://www.nbcnews.com/health/health-news/will-covid-vaccine-be-safe-what-scientists-want-see-n1248466

Nov. 21, 2020

A Gallup poll in November found that 58 percent of Americans say they would get a Covid-19 vaccine, up from a low of 50 percent in September. But there are still worries that the speed of developing and testing the vaccines may have compromised their scientific integrity.

........

at 95% effectiveness and 58% willing to take vaccine now in U.S, you are almost there with the herd immunity requirement of 60%


as more and more convincing data surfaces with people living normal after vaccination...and imposition of travel restriction to those not vaccinated...the willingness to take vaccine can only become stronger day by day...

https://www.nbcnews.com/health/health-news/will-covid-vaccine-be-safe-what-scientists-want-see-n1248466

Nov. 21, 2020

A Gallup poll in November found that 58 percent of Americans say they would get a Covid-19 vaccine, up from a low of 50 percent in September. But there are still worries that the speed of developing and testing the vaccines may have compromised their scientific integrity.

........

at 95% effectiveness and 58% willing to take vaccine now in U.S, you are almost there with the herd immunity requirement of 60%


as more and more convincing data surfaces with people living normal after vaccination...and imposition of travel restriction to those not vaccinated...the willingness to take vaccine can only become stronger day by day...

Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna

https://www.fool.com/investing/2020/11/20/coronavirus-vaccine-maker-past-pfizer-moderna/

Nov 20, 2020

J&J's coronavirus vaccine candidate, though, requires only one dose.

This could give J&J a significant competitive advantage over its rivals. A single-dose vaccine would have a lower cost than a two-dose regimen. People would also be more likely to want to receive a vaccine that they only have to take once.

Johnson & Johnson also won't have the ultra-cold storage requirements that Pfizer's vaccine has. Its COVID-19 vaccine can remain stable for up to two years at around minus four degrees Fahrenheit and for up to three months at temperatures between around 35 degrees and 46 degrees Fahrenheit.

In addition, J&J beats Moderna when it comes to production capacity. Moderna has stated that it will be able to make around 500 million doses of mRNA-1273 next year, although the biotech says that it could "possibly" up that to 1 billion doses. J&J is on track to produce more than 1 billion doses per year.

Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna

https://www.fool.com/investing/2020/11/20/coronavirus-vaccine-maker-past-pfizer-moderna/

Nov 20, 2020

J&J's coronavirus vaccine candidate, though, requires only one dose.

This could give J&J a significant competitive advantage over its rivals. A single-dose vaccine would have a lower cost than a two-dose regimen. People would also be more likely to want to receive a vaccine that they only have to take once.

Johnson & Johnson also won't have the ultra-cold storage requirements that Pfizer's vaccine has. Its COVID-19 vaccine can remain stable for up to two years at around minus four degrees Fahrenheit and for up to three months at temperatures between around 35 degrees and 46 degrees Fahrenheit.

In addition, J&J beats Moderna when it comes to production capacity. Moderna has stated that it will be able to make around 500 million doses of mRNA-1273 next year, although the biotech says that it could "possibly" up that to 1 billion doses. J&J is on track to produce more than 1 billion doses per year.

Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna

https://www.fool.com/investing/2020/11/20/coronavirus-vaccine-maker-past-pfizer-moderna/

Nov 20, 2020

J&J's coronavirus vaccine candidate, though, requires only one dose.

This could give J&J a significant competitive advantage over its rivals. A single-dose vaccine would have a lower cost than a two-dose regimen. People would also be more likely to want to receive a vaccine that they only have to take once.

Johnson & Johnson also won't have the ultra-cold storage requirements that Pfizer's vaccine has. Its COVID-19 vaccine can remain stable for up to two years at around minus four degrees Fahrenheit and for up to three months at temperatures between around 35 degrees and 46 degrees Fahrenheit.

In addition, J&J beats Moderna when it comes to production capacity. Moderna has stated that it will be able to make around 500 million doses of mRNA-1273 next year, although the biotech says that it could "possibly" up that to 1 billion doses. J&J is on track to produce more than 1 billion doses per year.

Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna

https://www.fool.com/investing/2020/11/20/coronavirus-vaccine-maker-past-pfizer-moderna/

Nov 20, 2020

J&J's coronavirus vaccine candidate, though, requires only one dose.

This could give J&J a significant competitive advantage over its rivals. A single-dose vaccine would have a lower cost than a two-dose regimen. People would also be more likely to want to receive a vaccine that they only have to take once.

Johnson & Johnson also won't have the ultra-cold storage requirements that Pfizer's vaccine has. Its COVID-19 vaccine can remain stable for up to two years at around minus four degrees Fahrenheit and for up to three months at temperatures between around 35 degrees and 46 degrees Fahrenheit.

In addition, J&J beats Moderna when it comes to production capacity. Moderna has stated that it will be able to make around 500 million doses of mRNA-1273 next year, although the biotech says that it could "possibly" up that to 1 billion doses. J&J is on track to produce more than 1 billion doses per year.

Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna

https://www.fool.com/investing/2020/11/20/coronavirus-vaccine-maker-past-pfizer-moderna/

Nov 20, 2020

J&J's coronavirus vaccine candidate, though, requires only one dose.

This could give J&J a significant competitive advantage over its rivals. A single-dose vaccine would have a lower cost than a two-dose regimen. People would also be more likely to want to receive a vaccine that they only have to take once.

Johnson & Johnson also won't have the ultra-cold storage requirements that Pfizer's vaccine has. Its COVID-19 vaccine can remain stable for up to two years at around minus four degrees Fahrenheit and for up to three months at temperatures between around 35 degrees and 46 degrees Fahrenheit.

In addition, J&J beats Moderna when it comes to production capacity. Moderna has stated that it will be able to make around 500 million doses of mRNA-1273 next year, although the biotech says that it could "possibly" up that to 1 billion doses. J&J is on track to produce more than 1 billion doses per year.

Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna

https://www.fool.com/investing/2020/11/20/coronavirus-vaccine-maker-past-pfizer-moderna/

Nov 20, 2020

J&J's coronavirus vaccine candidate, though, requires only one dose.

This could give J&J a significant competitive advantage over its rivals. A single-dose vaccine would have a lower cost than a two-dose regimen. People would also be more likely to want to receive a vaccine that they only have to take once.

Johnson & Johnson also won't have the ultra-cold storage requirements that Pfizer's vaccine has. Its COVID-19 vaccine can remain stable for up to two years at around minus four degrees Fahrenheit and for up to three months at temperatures between around 35 degrees and 46 degrees Fahrenheit.

In addition, J&J beats Moderna when it comes to production capacity. Moderna has stated that it will be able to make around 500 million doses of mRNA-1273 next year, although the biotech says that it could "possibly" up that to 1 billion doses. J&J is on track to produce more than 1 billion doses per year.

many people still dont get the meaning of 95% effective vaccine.

with current desperation from all businesses worldwide, vaccination worldwide will be done within months

every single business - you name it...will want to help to get this done as quick as possible, people cant wait for travel and holidays for life to return to normal

its done deal - max 12 months and the economy will be booming with added boost from pent up demand

its not easy to find an investment that gives 10% return in a year

you need to see the future in advance and take a strong bet